FdaApplication
ANDA 214113
Identifiers
- fda_app_no: ANDA214113
Properties
| Property | Value |
|---|---|
| applicant_name | RHODES PHARMACEUTICALS LP |
| application_type | ANDA |
| approval_date | 2023-05-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| THEOPHYLLINE | THEOPHYLLINE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
1 product